Anne Gurnett-Bander

Title: Anne Gurnett-Bander: Innovator in Antibody Development

Introduction

Anne Gurnett-Bander is a prominent inventor based in Carmel, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of human antibodies for therapeutic use. With a total of 3 patents, her work focuses on combating viral infections, specifically respiratory syncytial virus (RSV).

Latest Patents

One of her latest patents is titled "Human antibodies to respiratory syncytial virus F protein and methods of use thereof." This invention provides fully human antibodies that bind to the F protein of RSV. The antibodies are designed to prevent the fusion of the virus with the cell membrane, thereby inhibiting cell-to-cell spread of the virus. This innovation offers a means of preventing RSV infection and treating patients suffering from the infection, while also ameliorating symptoms or complications associated with the viral infection. Additionally, these antibodies may be useful for diagnosing RSV infections.

Career Highlights

Anne Gurnett-Bander is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to advance her research in antibody development. Her work has the potential to significantly impact the treatment of viral infections and improve patient outcomes.

Collaborations

Throughout her career, Anne has collaborated with notable colleagues, including David Perez-Caballero and Sumathi Sivapalasingam. These collaborations have further enhanced her research and contributed to the success of her innovations.

Conclusion

Anne Gurnett-Bander is a trailblazer in the field of antibody research, with a focus on developing effective treatments for viral infections. Her contributions are paving the way for advancements in medical science and improving healthcare outcomes for patients.